PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 160 filers reported holding PTC THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $109,000 | 0.0% | 15,580 | -8.1% | 0.10% | +6.5% |
Q1 2016 | $109,000 | -80.8% | 16,952 | -3.4% | 0.09% | -77.7% |
Q4 2015 | $568,000 | +11.2% | 17,542 | -8.4% | 0.41% | +13.5% |
Q3 2015 | $511,000 | -44.6% | 19,155 | -0.1% | 0.36% | -37.7% |
Q2 2015 | $923,000 | +15.2% | 19,169 | +45.5% | 0.58% | +25.6% |
Q1 2015 | $801,000 | +8.7% | 13,171 | -7.5% | 0.46% | +0.6% |
Q4 2014 | $737,000 | – | 14,243 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |